JPRN-UMIN000024905已完成未知
A randomized, open-label, crossover study to evaluate ICS/LABA treatment versus LAMA/LABA treatment in COPD with eosinophilic inflammation - COPD and eosinophilic inflammation.
Department of Respiratory Medicine, Japanese Red Cross Ishinomaki Hospital0 个研究点目标入组 25 人开始时间: 2016年11月21日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Asthma overlap (ACOS); history of lung resection; using inhaled or oral corticosteroid; receiving anti-IgE therapy; and exacerbation of COPD in the 4 weeks.
研究者
相似试验
已完成
不适用
An open-label, randomized crossover study to evaluate the pharmacokinetics, bioavailability, bioequivalence, and food effect following administration of Oxybate Formulations in healthy subjects.NL-OMON41817Jazz Pharmaceuticals60
已完成
不适用
An open-label, randomized crossover study to evaluate the effect of ASP1941 on the pharmacokinetics, pharmacodynamics, safety and tolerability of glimepiride in healthy subjects and vice versa.NL-OMON34715Astellas Pharma26
撤回
不适用
An open-label, randomized, crossover study to evaluate the pharmacokinetics, bioavailability, and bioequivalence following administration of JZP-507 oral solution and Xyrem®in healthy subjects.cataplexynarcolepsy10040998NL-OMON45490Jazz Pharmaceuticals60
进行中（未招募）
不适用
Patient preferences for Eucreas® versus Victoza® in Type 2 Diabetes mellitus patientstype 2 diabetes mellitusMedDRA version: 14.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2011-003818-16-DEovartis Pharma GmbH
已完成
不适用
Randomized, open-label, crossover study to evaluaute an effects of genetic polymorphism on pharmacokinetic & pharmacodynamic interactions of clopidogrel and cilostazol in Korean healthy adult volunteersKCT0000443Inje University Busan Paik Hospital27